Exome sequencing - Exome sequencing of colorectal cancer tumor and mismatch repair-deficient tumors.
From 01-08-2013 to 28-02-2014
Description
To unravel the complex genomic variation of colorectal cancer (CRC), SymBioSys is going to sequence in the next months the exomes 300 CRC tumors. The samples and cost for sequencing reagens are provided through the FP7-funded Angiopredict EU-project. Furthermore we are going to sequence 100 mismatch repair (MMR) deficient tumors. The funding for the experiments of the sequencing of the MMR deficient tumors is provided by projects funded by FWO and Belgian Foundation against Cancer. For an efficient analysis of this large number of exomes within our strict time schedule, we need the powerfull computational resources such as the TIER1. The pipelines we willl adapt for the use on TIER1 will be shared and discussed within the collaborating groups of the symbiosys project.Team
- Yves Moreau, Co-promoter
- Diether Lambrechts, Promoter (External)
- Bram Boeckx, Team member (External)
Financing
Funding: OTHER - Other Funding Agencies
Program/Grant Type: VSC - Vlaams Supercomputing Centrum
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.